Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
EP / DBI is diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. The protein is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor is also known to mediate the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent adrenal steroidogenesis. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have been described for this gene.
Gene Name: | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
Synonyms: | DBI, ACBP, Acyl-CoA-binding protein, CCK-RP, ACBD1, GABA receptor modulator, EP, Endozepine |
Target Sequences: | NM_020548 NP_065438.1 P07108 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.